<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Zhejiang Univ Sci B</journal-id>
<journal-id journal-id-type="iso-abbrev">J Zhejiang Univ Sci B</journal-id>
<journal-id journal-id-type="publisher-id">JZUS</journal-id>
<journal-title-group>
<journal-title>Journal of Zhejiang University. Science. B</journal-title>
</journal-title-group>
<issn pub-type="ppub">1673-1581</issn>
<issn pub-type="epub">1862-1783</issn>
<publisher>
<publisher-name>Zhejiang University Press</publisher-name>
<publisher-loc>Hangzhou</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30507077</article-id>
<article-id pub-id-type="pmc">6305257</article-id>
<article-id pub-id-type="doi">10.1631/jzus.B1800162</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An ensemble-based likelihood ratio approach for family-based genomic risk prediction<xref ref-type="fn" rid="FN01">*</xref>
<xref ref-type="fn" rid="FN02">#</xref>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>An</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Chang-shuai</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Da-hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Liang-wen</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Cheng-yin</given-names>
</name>
<xref ref-type="corresp" rid="cor01">†</xref>
<xref ref-type="author-notes" rid="CorAuth">‡</xref>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>Department of Health Management, School of Medicine, Hangzhou Normal University, Hangzhou 310036, China</aff>
<aff id="aff2">
<label>2</label>Department of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX 76107, USA</aff>
<aff id="aff3">
<label>3</label>HBI Solutions Inc, Palo Alto, CA 94301, USA</aff>
<aff id="aff4">
<label>4</label>Department of Preventive Medicine, School of Medicine, Hangzhou Normal University, Hangzhou 310036, China</aff>
<aff id="aff5">
<label>5</label>Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA</aff>
<author-notes>
<fn id="CorAuth">
<label>‡</label>
<p>Corresponding Author</p>
</fn>
<corresp id="cor01">†E-mail:<email>yechengyin@hznu.edu.cn</email></corresp>
<fn fn-type="COI-statement">
<p><bold>Compliance with ethics guidelines:</bold> Hui AN, Chang-shuai WEI, Oliver WANG, Da-hui WANG, Liang-wen XU, Qing LU, and Cheng-yin YE declare that they have no conflict of interest.</p>
<p>This article does not contain any studies with human or animal subjects performed by any of the authors.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2018</year>
</pub-date>
<volume>19</volume>
<issue>12</issue>
<fpage>935</fpage>
<lpage>947</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2018</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>Objective: As one of the most popular designs used in genetic research, family-based design has been well recognized for its advantages, such as robustness against population stratification and admixture. With vast amounts of genetic data collected from family-based studies, there is a great interest in studying the role of genetic markers from the aspect of risk prediction. This study aims to develop a new statistical approach for family-based risk prediction analysis with an improved prediction accuracy compared with existing methods based on family history. Methods: In this study, we propose an ensemble-based likelihood ratio (ELR) approach, Fam-ELR, for family-based genomic risk prediction. Fam-ELR incorporates a clustered receiver operating characteristic (ROC) curve method to consider correlations among family samples, and uses a computationally efficient tree-assembling procedure for variable selection and model building. Results: Through simulations, Fam-ELR shows its robustness in various underlying disease models and pedigree structures, and attains better performance than two existing family-based risk prediction methods. In a real-data application to a family-based genome-wide dataset of conduct disorder, Fam-ELR demonstrates its ability to integrate potential risk predictors and interactions into the model for improved accuracy, especially on a genome-wide level. Conclusions: By comparing existing approaches, such as genetic risk-score approach, Fam-ELR has the capacity of incorporating genetic variants with small or moderate marginal effects and their interactions into an improved risk prediction model. Therefore, it is a robust and useful approach for high-dimensional family-based risk prediction, especially on complex disease with unknown or less known disease etiology.</p>
</abstract>
<kwd-group>
<kwd>Family-based study</kwd>
<kwd>Genetic risk prediction</kwd>
<kwd>High-dimensional data</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>Crosschecked</meta-name>
<meta-value>Nov. 8, 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>